Vaccinex

Read more
Maurice Zauderer's photo - President & CEO of Vaccinex

President & CEO

Maurice Zauderer

CEO Approval Rating

89/100

Founded:

2001

Status:

PublicIndependent CompanyNASDAQVCNX

VACCINEX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Maurice Zauderer

President & CEO

- -
44
$84M
$1.5M
View Profile
1

Severin Schwan

CEO

89/100
100,000
$600K
$66.1B
View Profile
2

Paul Bolno

President & CEO

87/100
250
$227.8M
$15.9M
View Profile
3

Matthew Kapusta

CEO

83/100
332
$163.1M
$500.2M
View Profile
4

Markus Renschler

President & CEO

90/100
31
$296.1M
View Profile
5

Anthony S. Marucci

President & CEO

89/100
133
$562.7M
$5.4M
View Profile
6

CEO

- -
55
- -
$3.4M
View Profile
7

John Donovan

CEO

69/100
175
$120.4M
$4.5M
View Profile
8

Sergio Finkielsztein

President & CEO

68/100
32
- -
$1.3M
View Profile
9

CEO

- -
99
- -
$19.4M
View Profile
10

CEO

- -
34
- -
$5.9M
View Profile

Missing a competitor? Contribute!

Roche is Vaccinex's #1 rival. Roche is a Public company that was founded in Basel, Basel-Country in 1896. Like Vaccinex, Roche also works within the Biotechnology field. Roche has 99,956 more employees vs. Vaccinex.

Wave Life Sciences is perceived as one of Vaccinex's biggest rivals. Wave Life Sciences was founded in 2012, and is headquartered in Cambridge, Massachusetts. Like Vaccinex, Wave Life Sciences also operates in the Biotechnology sector. Wave Life Sciences generates $18.6M more revenue vs. Vaccinex.

uniQure is a top competitor of Vaccinex. uniQure is a Public company that was founded in 1998 in Amsterdam, Noord-Holland. Like Vaccinex, uniQure also operates in the Biotechnology space. Compared to Vaccinex, uniQure has 288 more employees.

Vaccinex Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.5M

Vaccinex's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 3.4B. Over the last two quarters, Vaccinex's revenue has grown by 36%. Specifically, in Q1 2021's revenue was $ < 1M; in Q3 2020, it was $ < 1M.

Vaccinex Acquisitions

No recent acquisitions found related to Vaccinex

Vaccinex Funding History

Since Vaccinex was founded in 2001, it has participated in 9 rounds of funding. In total Vaccinex has raised $84.0M. Vaccinex's last funding round was on Aug 2020 for a total of $8.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Aug 2020
$8M
-
Equity
Jul 2020
$4M
-
Debt - PPP (CARES Act)
Apr 2020
$1M - $2M

U.S. Small Business Administration.

Equity
Jan 2020
$7.5M
-
Grant
Dec 2019
$3M

Since Vaccinex was founded in 2001, it has participated in 9 rounds of funding. In total Vaccinex has raised $84.0M. Vaccinex's last funding round was on Aug 2020 for a total of $8.0M

Vaccinex Investments

No recent investments found related to Vaccinex

Vaccinex News

May 19, 2021Markets Insider

Vaccinex to Present at the Jefferies 2021 Virtual Healthcare Conference

ROCHESTER, N.Y., May 19, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage bio... See more »
May 17, 2021BioSpace

Vaccinex Reports First Quarter 2021 Financial Results and Provides Corporate Update

Initiated Phase 2 study of pepinemab in combination with KEYTRUDA® in advanced, recurrent or metastat... See more »
March 16, 2021BioSpace

Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update

Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated app... See more »
March 9, 2021MarketScreener

AD/PD 2021 Presentation

(marketscreener.com) RESULTS OF PHASE 2 HUNTINGTON'S DISEASE TRIAL OF ANTI-SEMAPHORIN 4D ANTIBODY PEP... See more »
February 22, 2021Pulse2.0

Why It Happened

The stock price of Vaccinex, Inc. (Nasdaq: VCNX) increased over 18% during intraday trading today. Th... See more »
February 19, 2021Business Insider

Vaccinex stock soars 223% on partnership deals using its antibody discovery platform

Vaccinex stock spiked after reaching two deals with pharmaceutical companies that will use its techno... See more »
February 19, 2021MarketWatch

Vaccinex's stock soars toward record gain on record volume after deals with 'prominent' drug makers

Shares of Vaccinex Inc. soared toward a record rally on record volume Friday, after the biotechnology... See more »

Vaccinex Press Releases

February 19, 2021LD Micro

Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb Platform

Read this press release and other recent news about Vaccinex Inc. (VCNX) at ldmicro.com... See more »
January 5, 2021GlobeNewswire

Vaccinex to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

ROCHESTER, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage bi... See more »
December 10, 2019GlobeNewswire

Vaccinex Announces $3 Million Award from the Alzheimer's Drug Discovery Foundation

Pepinemab (VX15), an experimental Vaccinex drug previously shown to prevent reduced brain glucose tra... See more »
November 12, 2019GlobeNewswire

Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small... See more »
September 6, 2019GlobalNewswire

Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Vaccinex, Inc.- VCNX

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces it has commenced an investiga... See more »

Social Media

Vaccinex Headquarters

1895 Mount Hope Avenue

Rochester, New York14620

585-271-2700

Driving Directions »

Trending Companies

Vaccinex Summary

ABOUT

Overview

Vaccinex is a biotechnology company that develops and commercializes therapeutics for the treatment of cancer and neurodegenerative diseases. Vaccinex was founded in 2001. Vaccinex's headquarters is located in Rochester, New York, USA 14620. It has ra...

CEO

Vaccinex's President & CEO, Maurice Zauderer, currently has an approval rating of 89%. Vaccinex's primary competitors are Roche, Wave Life Sciences & uniQure.

Frequently Asked Questions about Vaccinex

  1. When was Vaccinex founded?

    Vaccinex was founded in 2001
  2. Who is Vaccinex's CEO?

    Vaccinex's CEO is Maurice Zauderer
  3. How much revenue does Vaccinex generate?

    Vaccinex generates $1.5M in revenue
  4. How much funding does Vaccinex have?

    Vaccinex has historically raised $84M in funding
  1. Where is Vaccinex's headquarters?

    Vaccinex's headquarters is in Rochester New York, USA
  2. How many employees does Vaccinex have?

    Vaccinex has 44 employees
  3. What sector does Vaccinex operate in?

    Vaccinex is in Biotechnology
  4. Who are Vaccinex's competitors?

    Vaccinex's top competitors are Roche, Wave Life Sciences, uniQure